Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase 2 1Phase 1/2 1

Status

Completed 21Terminated 7Unknown 6Active not recruiting 6Recruiting 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1NIH 1INDUSTRY 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 3Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Oligospermia 1Fibrosis 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Interventional × BCG Vaccine × Clear all
NCT02948543 2023-06-18

BCG+MM

University of Sydney

Phase 3 Unknown
501 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT05701332 2023-01-27

Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume

Assiut University

Phase 4 Unknown
25 enrolled

Fibrosis, Oligospermia

NCT03664869 2021-04-01

FB10

Turku University Hospital

Phase 3 Unknown
300 enrolled
Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT03790384 2018-12-31

MITOBCG

Azienda Ospedaliera "Sant'Andrea"

Phase 4 Unknown
140 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00007826 2013-09-20

Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00514072 2012-08-09

Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer

Kael-GemVax Co., Ltd.

Phase 2 Unknown
54 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡